US Patent 8927551 Isoxazolines as inhibitors of fatty acid amide hydrolase
Patent 8927551 was granted and assigned to Infinity Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8927551 Isoxazolines as inhibitors of fatty acid amide hydrolase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
